» Articles » PMID: 33258084

The Cardiovascular Determinants of Physical Function in Patients with End-stage Kidney Disease on Haemodialysis

Abstract

Patients with end-stage kidney disease (ESKD) are often sedentary and decreased functional capacity associates with mortality. The relationship between cardiovascular disease (CVD) and physical function has not been fully explored. Understanding the relationships between prognostically relevant measures of CVD and physical function may offer insight into how exercise interventions might target specific elements of CVD. 130 patients on haemodialysis (mean age 57 ± 15 years, 73% male, dialysis vintage 1.3 years (0.5, 3.4), recruited to the CYCLE-HD trial (ISRCTN11299707), underwent cardiovascular phenotyping with cardiac MRI (left ventricular (LV) structure and function, pulse wave velocity (PWV) and native T1 mapping) and cardiac biomarker assessment. Participants completed the incremental shuttle walk test (ISWT) and sit-to-stand 60 (STS60) as field-tests of physical function. Linear regression models identified CV determinants of physical function measures, adjusted for age, gender, BMI, diabetes, ethnicity and systolic blood pressure. Troponin I, PWV and global native T1 were univariate determinants of ISWT and STS60 performance. NT pro-BNP was a univariate determinant of ISWT performance. In multivariate models, NT pro-BNP and global native T1 were independent determinants of ISWT and STS60 performance. LV ejection fraction was an independent determinant of ISWT distance. However, age and diabetes had the strongest relationships with physical function. In conclusion, NT pro-BNP, global native T1 and LV ejection fraction were independent CV determinants of physical function. However, age and diabetes had the greatest independent influence. Targeting diabetic care may ameliorate deconditioning in these patients and a multimorbidity approach should be considered when developing exercise interventions.

Citing Articles

Inflammation Links Cardiac Injury and Renal Dysfunction: A Cardiovascular Magnetic Resonance Study.

Xie X, Chen J, Yu L, Sun J, Zhao C, Duan Q Rev Cardiovasc Med. 2024; 25(4):148.

PMID: 39076541 PMC: 11263989. DOI: 10.31083/j.rcm2504148.


T and T Mapping in Uremic Cardiomyopathy: An Update.

Arcari L, Camastra G, Ciolina F, Danti M, Cacciotti L Card Fail Rev. 2022; 8:e02.

PMID: 35111336 PMC: 8790724. DOI: 10.15420/cfr.2021.19.

References
1.
Hinojar R, Foote L, Ucar E, Jackson T, Jabbour A, Yu C . Native T1 in discrimination of acute and convalescent stages in patients with clinical diagnosis of myocarditis: a proposed diagnostic algorithm using CMR. JACC Cardiovasc Imaging. 2014; 8(1):37-46. DOI: 10.1016/j.jcmg.2014.07.016. View

2.
Wilkinson T, Clarke A, Nixon D, Hull K, Song Y, Burton J . Prevalence and correlates of physical activity across kidney disease stages: an observational multicentre study. Nephrol Dial Transplant. 2019; 36(4):641-649. DOI: 10.1093/ndt/gfz235. View

3.
Wilkinson PhD T, Xenophontos MSc S, Gould PhD D, Vogt PhD B, Viana PhD J, Smith PhD A . Test-retest reliability, validation, and "minimal detectable change" scores for frequently reported tests of objective physical function in patients with non-dialysis chronic kidney disease. Physiother Theory Pract. 2018; 35(6):565-576. DOI: 10.1080/09593985.2018.1455249. View

4.
Ley S, Eichhorn J, Ley-Zaporozhan J, Ulmer H, Schenk J, Kauczor H . Evaluation of aortic regurgitation in congenital heart disease: value of MR imaging in comparison to echocardiography. Pediatr Radiol. 2007; 37(5):426-36. DOI: 10.1007/s00247-007-0414-4. View

5.
Ehsani A, Biello D, Seals D, Austin M, Schultz J . The effect of left ventricular systolic function on maximal aerobic exercise capacity in asymptomatic patients with coronary artery disease. Circulation. 1984; 70(4):552-60. DOI: 10.1161/01.cir.70.4.552. View